2048x2048 HgCdTe focal plane arrays for astronomy applications

Autor: Kadri Vural, Lester J. Kozlowski, C. A. Chen, Jose M. Arias, Jagmohan Bajaj, Donald E. Cooper, Donald N. B. Hall, J. A. Pinter, Klaus-Werner Hodapp, G. G. Price, Craig A. Cabelli, William E. Kleinhans, Gary L. Bostrup

Publikováno v: SPIE Proceedings.

Rockwell is developing the world's largest HgCdTe IR focal plane array (FPA) for astronomy and low background applications. The format of the device is a hybrid 2048 X 2048 with a unit cell size of 18 micrometers X 18 micrometers . SWIR detectors wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1468b56a3e732d000be6b17c0f576b91
https://doi.org/10.1117/12.354532

An Overview of Real-World Data Infrastructure for Cancer Research.

Autor: Price G; Division of Cancer Sciences, University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK. Electronic address: gareth.price@manchester.ac.uk., Peek N; Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, UK; The Healthcare Improvement Studies Institute (THIS Institute), University of Cambridge, Cambridge, UK., Eleftheriou I; Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, UK., Spencer K; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK; Leeds Teaching Hospitals NHS Trust, Leeds, UK; National Disease Registration Service, NHS England, UK., Paley L; National Disease Registration Service, NHS England, UK., Hogenboom J; Department of Radiation Oncology (Maastro), GROW-School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands., van Soest J; Department of Radiation Oncology (Maastro), GROW-School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands; Brightlands Institute for Smart Society (BISS), Faculty of Science and Engineering, Maastricht University, Maastricht, The Netherlands., Dekker A; Department of Radiation Oncology (Maastro), GROW-School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands., van Herk M; Division of Cancer Sciences, University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK., Faivre-Finn C; Division of Cancer Sciences, University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK.

Publikováno v: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2024 Mar 19. Date of Electronic Publication: 2024 Mar 19.

Impact of the COVID-19 Pandemic on Outcomes for Patients with Lung Cancer Receiving Curative-intent Radiotherapy in the UK.

Autor: Fornacon-Wood I; University of Manchester, Manchester, UK. Electronic address: Isabella.fornacon-wood@postgrad.manchester.ac.uk., Banfill K; University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK., Ahmad S; Guy's and St Thomas' NHS Foundation Trust, London, UK., Britten A; Brighton and Sussex University Hospitals NHS Trust, Brighton, UK., Carson C; The Northern Ireland Cancer Centre, Belfast, UK., Dorey N; Torbay and South Devon NHS Foundation Trust, Torquay, UK., Hatton M; Weston Park Hospital, Sheffield, UK., Hiley C; University College London Hospitals, London, UK., Thippu Jayaprakash K; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Jegannathen A; University Hospitals North Midlands, Stoke on Trent, UK., Kidd AC; Singleton Hospital, Swansea, UK., Koh P; Royal Wolverhampton NHS Trust, Wolverhampton, UK., Panakis N; Oxford University Hospitals NHS Trust, Oxford, UK., Peedell C; The James Cook University Hospital, Middlesborough, UK., Peters A; Beatson West of Scotland Cancer Centre, Glasgow, UK., Pope A; Clatterbridge Cancer Centre, Liverpool, UK., Powell C; Velindre Cancer Centre, Cardiff, UK., Stilwell C; Aberdeen Royal Infirmary, Aberdeen, UK., Thomas B; Swansea Bay University Hospital, Swansea, UK., Toy E; Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Wicks K; University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK., Wood V; University Hospitals Southampton NHS Foundation Trust, Southampton, UK., Yahya S; University Hospitals Birmingham, Birmingham, UK., Price G; University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK., Faivre-Finn C; University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK.

Publikováno v: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2023 Oct; Vol. 35 (10), pp. e593-e600. Date of Electronic Publication: 2023 Jul 22.

Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature Review.

Autor: Gaito S; Proton Clinical Outcomes Unit, The Christie NHS Foundation Trust, Manchester, UK; Division of Clinical Cancer Science, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. Electronic address: Simona.gaito@nhs.net., Burnet N; Clinical Oncology, Proton Beam Therapy Centre, The Christie NHS Foundation Trust, Manchester, UK., Aznar M; Division of Clinical Cancer Science, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK., Crellin A; Division of Clinical Cancer Science, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; NHS England National Clinical Lead Proton Beam Therapy, UK., Indelicato DJ; University of Florida Department of Radiation Oncology, Jacksonville, Florida, USA., Ingram S; Division of Clinical Cancer Science, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK., Pan S; Clinical Oncology, Proton Beam Therapy Centre, The Christie NHS Foundation Trust, Manchester, UK., Price G; Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK., Hwang E; Clinical Oncology, Proton Beam Therapy Centre, The Christie NHS Foundation Trust, Manchester, UK; Institute of Medical Physics, School of Physics, University of Sydney, Sydney, New South Wales, Australia., France A; Proton Clinical Outcomes Unit, The Christie NHS Foundation Trust, Manchester, UK., Smith E; Proton Clinical Outcomes Unit, The Christie NHS Foundation Trust, Manchester, UK; Division of Clinical Cancer Science, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Clinical Oncology, Proton Beam Therapy Centre, The Christie NHS Foundation Trust, Manchester, UK., Whitfield G; Division of Clinical Cancer Science, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Clinical Oncology, Proton Beam Therapy Centre, The Christie NHS Foundation Trust, Manchester, UK.

Publikováno v: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2022 Jun; Vol. 34 (6), pp. e225-e237. Date of Electronic Publication: 2022 Jan 15.

Evaluation of Prognostic and Predictive Models in the Oncology Clinic.

Autor: Craddock M; University of Manchester, Radiotherapy Related Research Group, Division of Cancer Sciences, School of Medical Sciences, Manchester, UK. Electronic address: matthew.craddock@postgrad.manchester.ac.uk., Crockett C; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK., McWilliam A; University of Manchester, Radiotherapy Related Research Group, Division of Cancer Sciences, School of Medical Sciences, Manchester, UK., Price G; University of Manchester, Radiotherapy Related Research Group, Division of Cancer Sciences, School of Medical Sciences, Manchester, UK., Sperrin M; Centre for Health Informatics, Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK., van der Veer SN; Centre for Health Informatics, Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK., Faivre-Finn C; University of Manchester, Radiotherapy Related Research Group, Division of Cancer Sciences, School of Medical Sciences, Manchester, UK; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.

Publikováno v: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2022 Feb; Vol. 34 (2), pp. 102-113. Date of Electronic Publication: 2021 Dec 23.